equitysell

NCI

Our current stance on NCI is informed by company SEC filings for COHR and a short‑term market‑microstructure read. The published analysis recommends a sell based on recent 10‑Q disclosures and a low‑participation price drift.

Opportunity
90 / 100
Current score
-1.60
Thesis calls
2
Active ticker theses
2

Recent proof-backed thesis calls

Recent source material: Coherent Corp. Form 10‑Q filings for the quarters ended 2025‑12‑31 and 2026‑03‑31 (SEC EDGAR). These filings provide the underlying financial statements, cash‑flow activity, balance sheet detail and disclosed noncontrolling interest movements referenced in our analysis.

COHERENT CORP.sec_filingsright

The provided excerpt is only the cover/registrant-identification portion of Coherent Corp.’s (COHR) 10‑Q for the quarter ended 2026‑03‑31. It contains no financial statements, segment results, guidance, risk updates, liquidity/debt detail, or MD&A content, so it does not support a directional investment conclusion.

Mentioned: May 6, 2026, 4:10 PM EDTConviction: 80 / 100Observed price: $1.06 on 2026-05-06Return: -31.96%
Source: COHR 10-Q report for 2026-03-31
COHERENT CORP.sec_filingsright

This source is only the cover/header portion of Coherent Corp.’s Form 10-Q for the quarter ended Dec 31, 2025. It confirms the filing and listing (NYSE: COHR) but contains no financial statements, segment results, guidance, or risk-factor updates to assess fundamentals or derive tradable implications.

Mentioned: Feb 4, 2026, 4:06 PM ESTConviction: 80 / 100Observed price: $1.16 on 2026-02-04Return: -31.96%
Source: COHR 10-Q report for 2025-12-31

Latest market-close explanation

Short‑term market read: NCI experienced a modest slip (-0.92%) in a narrow price range on sharply lower volume (~-57.9%). With no company news or earnings items, the move is most consistent with thin liquidity rather than a new fundamental catalyst. Key items to monitor: support ~1.07, resistance ~1.11, volume/market depth, and any sudden volume or filing‑related catalysts.

2026-07-24unavailable

No market-close explanation is available for `NCI` on 2026-07-24 because usable price history was not available. Reason: no_market_data.

Current stance

Current recommendation: sell. The sell view is driven by the interpretation of the COHR 10‑Q disclosures and a short‑term market‑structure signal (thin liquidity and a modest downward drift in NCI).

Recommendationsell
Authors1
Active ticker theses2
Latest pricen/a
Why now
  • sell via COHR 10-Q report for 2026-03-31 from https://www.sec.gov/edgar/search/ (confidence 0.80)
  • sell via COHR 10-Q report for 2025-12-31 from https://www.sec.gov/edgar/search/ (confidence 0.80)

Active and historical ticker theses

Active plays on file summarize the COHR 10‑Q reports (2025‑12‑31 and 2026‑03‑31). Each play points to the respective 10‑Q as the primary source document and includes the filing excerpts and financial tables used to inform our view.

Unlock full asset monitoring

Review the linked 10‑Q filings on SEC EDGAR for full financial detail (COHR). Monitor price action around the identified technical levels and watch for increased volume or company announcements that could change the short‑term view.